events

2026 MedTech Monitor

When:
This Month
Hosted By:
Fox Rothschild
People:
Location:
City Center

33 S. Sixth Street
Minneapolis, MN 55402

Location
Share on:

Join fellow MedTech industry leaders, including CEOs, venture capitalists, in-house legal counsel and regulatory professionals, for a can't-miss, full-day program of insights, discussions, practical takeaways and networking focused on today's most pressing topics.

The event kicks off with breakfast, features a networking lunch and concludes with a post-event reception.

8:00 am: Breakfast | Registration | Networking

8:30 am: Welcome Remarks 

8:45 am – 9:45 am: Optimizing Service Providers while Transitioning from Early to Late Stage

  • Patrice Kloss, Partner, Fox Rothschild (moderator)
  • Leota Pearson, Contract CFO, Leota L Pearson Consulting, LLC
  • Lisa Pritchard, VP of Regulatory, Quality, Clinical and Engineering, DuVal & Associates, P.A.
  • Ruth Vafek, Partner Fox Rothschild
  • Megan Osorio, CEO, Veranex

9:45 am – 10:45 am: Sales & Marketing – Regulatory Trends

  • Bryan Feldhaus, President of Legal-Regulatory and Compliance, DuVal & Associates, P.A. (moderator)
  • Dan Kosednar, VP of Regulatory Affairs and Healthcare Compliance Officer, HistoSonics
  • Michael Kujak, President & CEO, Francis Medical

10:45 am – 11:00 am: Morning Break

11:00 am – 11:30 am: Neurotech "State of the State" session

  • Jim Cavuoto, Publisher, Neurotech Reports

11:30 am – 12:15 pm: Artificial Intelligence: The Ins and Outs of Business Use

  • Mark McCreary, Partner, Chief Data & Artificial Intelligence Officer, Fox Rothschild

12:15 pm – 12:45 pm: Lunch | Networking

12:45 pm – 1:45 pm: Keynote: Update in FDA’s Regulation of Digital Health Technologies: How FDA is Approaching AI-Enabled Medical Devices

  • Ambreen Athar, Senior Digital Health Advisor in the FDA's Division of Digital Health Policy

1:45 pm – 2:45 pm: M&A Exits – Recent Trends

  • Kathryn Dehn, Partner, Fox Rothschild

2:45 pm – 3:00 pm: Afternoon Break

3:00 pm – 4:00 pm: Working Productively with FDA

  • Mark DuVal, CEO, DuVal & Associates, P.A.
  • Chris Lyle, VP of Evidence Strategy, DuVal & Associates, P.A.
  • Allison Komiyama, Senior Regulatory Strategist, DuVal & Associates, P.A.
  • Lisa Pritchard, VP of Regulatory, Quality, Clinical and Engineering, DuVal & Associates, P.A.

4:00 pm: Closing Remarks | Cocktail Reception